The only pure-play pot stock to pay a dividend should be significantly more profitable next year.
Raising cash can have its drawbacks.
Have pessimists had a change of heart, or is this simply profit-taking?
Consolidation among Canadian pot growers is inevitable.
This marijuana stock has been initiated at, or downgraded to, the equivalent of a sell rating four times in less than two months.
Unfortunately, being popular doesn't make this pot stock a worthy investment.
MedMen's preliminary third-quarter sales results contain a number of red flags.
Planet 13's SuperStore is unlike anything the marijuana industry has ever seen.
Another Wall Street firm lists this "top pick" as a sell.
Canopy's $3.4 billion purchase of Acreage Holdings is unlike anything Wall Street or investors have ever seen.
There are some surprising marijuana stocks at the top and bottom of this list.
You can do more through a "my Social Security" account, or via the Social Security website, than you probably realize.
The green rush could have investors seeing green in pretty much any economic environment.
There may be more to pot-stock acquisitions than meets the eye.
Interest income is a lucrative business for the nation's most important social program.
The world is "going green" at an increasingly rapid pace.
Gary Cohn has little faith in the president's call for $26 billion in Social Security cuts in his 2020 federal budget.
The craziest thing is that you've probably never even heard of this pot stock before.
Surprise! Canopy Growth isn't No. 1 (or 2).
You'll probably be surprised by the answer.